Rep. Bucshon, DeGette Call for Passage of VALID Act, Respond to FDA’s Proposed Rule
Washington, October 4, 2023
WASHINGTON – Today, U.S. Representatives Larry Bucshon, M.D. (R-IN-08) and Diana DeGette (D-CO-01) released the statement below following the release of the FDA’s proposed rule to ensure safety and effectiveness of laboratory developed tests.
“The FDA’s proposed rule to provide greater oversight of laboratory developed tests recognizes the need for action in this space. Ultimately, to ensure the analytical and clinical validity of tests and promote patient safety, Congress must pass the Verifying Accurate, Leading-edge IVCT Development (VALID) Act,” said the Representatives. “This bipartisan legislation would provide a long overdue modernization of the regulatory framework of diagnostics, solidifying in law the FDA’s authority to review tests. We hope the conversation generated by the proposed rule will further educate our colleagues and the public on this important issue and highlight the need for Congress to pass the VALID Act.”
Congressman Larry Bucshon, M.D. represents Indiana’s 8th Congressional District in the United States House of Representatives and is a senior member of the House Energy and Commerce Committee.